- Home
- SACH vs PRE Comparison
SACH vs PRE Comparison
Compare SACH & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SACH
- PRE
- Stock Information
- Founded
- SACH 2010
- PRE 2014
- Country
- SACH United States
- PRE Hong Kong
- Employees
- SACH N/A
- PRE N/A
- Industry
- SACH Real Estate Investment Trusts
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- SACH Real Estate
- PRE Industrials
- Exchange
- SACH Nasdaq
- PRE Nasdaq
- Market Cap
- SACH 60.6M
- PRE 69.7M
- IPO Year
- SACH 2017
- PRE N/A
- Fundamental
- Price
- SACH $1.23
- PRE $5.71
- Analyst Decision
- SACH Buy
- PRE Buy
- Analyst Count
- SACH 2
- PRE 1
- Target Price
- SACH $2.25
- PRE $9.00
- AVG Volume (30 Days)
- SACH 518.7K
- PRE 12.3K
- Earning Date
- SACH 11-14-2024
- PRE 11-27-2024
- Dividend Yield
- SACH 19.51%
- PRE N/A
- EPS Growth
- SACH N/A
- PRE N/A
- EPS
- SACH N/A
- PRE N/A
- Revenue
- SACH $10,951,064.00
- PRE $25,561,362.00
- Revenue This Year
- SACH N/A
- PRE $50.97
- Revenue Next Year
- SACH N/A
- PRE $217.53
- P/E Ratio
- SACH N/A
- PRE N/A
- Revenue Growth
- SACH N/A
- PRE N/A
- 52 Week Low
- SACH $1.11
- PRE $2.85
- 52 Week High
- SACH $4.64
- PRE $7.84
- Technical
- Relative Strength Index (RSI)
- SACH 45.51
- PRE 52.78
- Support Level
- SACH $1.20
- PRE $5.58
- Resistance Level
- SACH $1.30
- PRE $6.00
- Average True Range (ATR)
- SACH 0.08
- PRE 0.31
- MACD
- SACH 0.02
- PRE -0.03
- Stochastic Oscillator
- SACH 41.38
- PRE 62.82
About SACH Sachem Capital Corp.
Sachem Capital Corp is a United States-based real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.